Childhood Malignant Neoplasm — Trials

Childhood Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,178 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 263
Recruiting: 158
Ph III recruiting: 9
Growth YoY: −7.4%
Industry share: 8%
Top sponsor: St. Jude Children's Research Hospital
Termination share: 19.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (92)

clinicaltrialsPublishedShowing 101–118 of 118 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00095940	Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors	completed	Phase 1 / Phase 2	52	National Cancer Institute (NCI)NIH	1	May 23, 2014	clinicaltrials
NCT00070525	Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma	completed	Phase 2	90	National Cancer Institute (NCI)NIH	1	Oct 8, 2013